Pharma Industry News
Printable Version   Email to a friend

Blood Pressure Drugs May Prevent Headaches

October 13, 2005

Blood pressure-lowering drugs may also help to prevent headache, according to recent findings by researchers in London.

The retrospective meta-analysis of data was published in the 11 October issue of Circulation, Journal of the American Heart Association and reported by MedPage Today on 11 October.

Researchers identified drugs in four classes-thiazides, beta-blockers, angiotensin converting enzyme (ACE) inhibitors, and angiotensin II receptor agonists-that reduced the incidence of headache. Data were derived from 94 randomized, placebo-controlled trials.

Study Methods and Results

Researchers examined 94 studies conducted from 1966 to 2001 in which fixed doses of blood pressure-lowering drugs were given and data on headaches were taken. All trials were double blind and lasted at least two weeks. Trials of calcium-channel blockers were excluded because drugs in this class are reputed to cause headache.

The data-review included 17,641 participants who received blood pressure-lowering drugs and 6,603 participants who received placebo. In those who received active treatment, systolic blood pressure decreased an average of 9.4 mm Hg and diastolic pressure decreased an average of 5.5 mm Hg.

In all groups receiving active blood pressure-lowering treatment, headache frequency was one-third lower (8%) than among the 6,603 participants who received placebo (12.4%). Additionally, treatment with any of the four classes of blood pressure-lowering drugs reduced the prevalence of headache.

"We are not saying that these drugs should be taken solely to prevent headaches, but this is a valuable associated benefit," said epidemiologist Malcolm Law, MSc, MBBS, at Queen Mary's School of Medicine and Dentistry of the University of London, according to MedPage Today.

However, Dr. Law stated that the data do not address the question of whether headaches disappear as blood pressure drops, or whether some other pharmacological mechanism in each drug class may explain the reduction in headache prevalence. He also noted that the link between blood pressure and headaches has been a "medical mystery for about 100 years," according to the MedPage Today report.

"The conclusion that the blood pressure-lowering drugs prevent headache is firm, and the conclusion that a higher blood pressure causes headache is likely but not corroborated by the observational studies (generally cross-sectional in design) on blood pressure and headache," Dr. Law and colleagues wrote in Circulation.

Dose-Response Link

Researchers observed a statistically significant dose-response relationship for diastolic pressure: in studies where diastolic pressure decreased by > 5 mm Hg, the reduction in headache prevalence was 13% greater. However, these data were derived from only one large trial. Omitting that trial's results makes the relationship between diastolic pressure decrease and headaches of marginal significance.

Source:
Drugs That Lower Blood Pressure Also Prevent Headaches MedPage Today, 11 October 2005.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
October 7, 2008
Audience: Pulmonary care health professionals and patients[UPDATE 10/07/2008] FDA informed healthcare professionals that FDA has...
October 3, 2008
Audience: Healthcare professionals, consumers [Posted 10/03/2008] FDA notified healthcare professionals of a Class I Recall of...
October 2, 2008
Audience: Physical medicine and rehabilitation specialists, anesthesia healthcare professionals, hospital surgical service...
September 30, 2008
Audience: Neurologists, cardiologists, consumers[Posted 09/30/2008] An FDA analysis provides new evidence that the use of statins...
More...
Latest Drug Information Updates

AdreView
AdreView is a diagnostic radiopharmaceutical agent indicated for use in the detection of rare neuroendocrine tumors in children and adults.

Sancuso
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Nplate
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

More...